Integra LifeSciences (NASDAQ: IART) reported Q2 EPS of $0.79, $0.03 better than the analyst estimate of $0.76. Revenue for the quarter came in at $0 versus the consensus estimate of $239.91 million.

Integra LifeSciences sees FY2015 EPS of $3.00-$3.10, versus the consensus of $3.11. Integra LifeSciences sees FY2015 revenue of $870-885 million, versus the consensus of $871.57 million.

For earnings history and earnings-related data on Integra LifeSciences (IART) click here.